Supply Chain Operations & Compliance in Pharma

Being able to deliver quality drug products to patients on-time is the top priority of bio-pharma. A seamless and compliant supply chain operation is therefore of utmost importance to drug developers. However, the pharma supply chain has become more complex and globalized over the last few years. The rise of virtual biotechs and supply networks, and the number of 3PLs involved, have made maintaining a round-the-clock operation a real challenge. Coupled with this, a recent report from McKinsey suggested pharma manufacturers could save $25 billion on supply chain inefficiencies.

URLs:
Brochure: https://go.evvnt.com/120563-1
Booking: https://go.evvnt.com/120563-2

Prices:
Pharma & Biotech Earlybird: USD 1499
Pharma & Biotech Standard: USD 2099
Solution Provider Earlybird: USD 2099
Solution Provider Standard: USD 2699

Speakers: Kevin Cook Sandoz, Glen Roberts AbbVie, William McGillian Merck & Co, George Donato Iroko Pharmaceuticals, Michael Sparozic Sanofi